pr-bio

Change company name to Pharma Research BIO

Disposal of division about GBIO

Obtain a government permission to manufacture medicines at Bio Plant in Gangneung

Request for approval of export items by Botulinum Toxins

Completed GMP inspection for The Ministry of Food and Drug Safety.

Completed construction of Plant only for Botulinum toxin

Plant only for Botulinum toxin reported BSL2

IND submission for Botulinum Toxin

Plant acquisition and remodeling in Gangneung(Botulinum Toxin Only)

Certified by the Corporate Capital Research Institute

Opening of R&D center in Gangneung

Report on R&D Center BSL2

listed on the KONEX

Engagement of consulting contract for EPO, hepatitis B vaccine, recombinant protein, and Multiple Sclerosis treatment

Founding BIOCND Co., Ltd.

Commencing the biopharmaceutical development consulting business